Page last updated: 2024-10-21

7-chlorokynurenic acid and Obesity

7-chlorokynurenic acid has been researched along with Obesity in 1 studies

7-chlorokynurenic acid: selective antagonist at the glycine modulatory site of the N-methyl-D-aspartate receptor complex; structure given in first source
7-chlorokynurenic acid : A quinolinemonocarboxylic acid that is quinaldic acid which is substituted by a hydroxy group at position 4 and by a chlorine at position 7. It is a potent NMDA glutamate receptor antagonist which antagonizes the strychnine-insensitive glycine site of the NMDA receptor. It also prevents neurodegeneration produced by quinolinic acid.

Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yue, JT1
Abraham, MA1
Bauer, PV1
LaPierre, MP1
Wang, P1
Duca, FA1
Filippi, BM1
Chan, O1
Lam, TK1

Other Studies

1 other study available for 7-chlorokynurenic acid and Obesity

ArticleYear
Inhibition of glycine transporter-1 in the dorsal vagal complex improves metabolic homeostasis in diabetes and obesity.
    Nature communications, 2016, 11-22, Volume: 7

    Topics: Animals; Brain; Diabetes Mellitus, Experimental; Diet, High-Fat; Energy Metabolism; Gene Expression

2016